EBO vs SPL

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

EBO

EBOS FPO NZ [EBO]

49LOW

SPL

STARPHARMA FPO [SPL]

49LOW

Score Breakdown

EBO SPL
Technical
71
48
Catalyst
67
65
Sentiment
50
50
Fundamental
100
72
Momentum
39
82
Risk Gate
50
50

Key Metrics

EBO Metric SPL
$3.8BMarket Cap$195.3M
256KAvg Volume (20d)1.7M
+0.6%Short Interest+0.1%
$38.23052-Week High$0.525
$17.78052-Week Low$0.082
+4.1%Daily Change+0.0%
$18.780Entry Price$0.465
+9.0%ROE-14.5%
+1.8%Profit Margin-22.2%

Active Signals

EBO Signals

●MACD momentum is picking up steam
●Volume surging at 4.6x normal while price climbs — real buying conviction behind this move
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.3x)
●Moderate revenue growth (+13%)
●Piotroski F-Score strong (8/9, low-confidence approx)

SPL Signals

●Stochastic is stretched into overbought — could need a breather
●Trading above both moving averages — the trend is your friend here
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (86 quarters)
●Moderate P/S ratio (13.4x)
●Strong revenue growth (+360%)
●EPS estimates revised downward (-10pts)

Ask Scout AI to compare EBO and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
EBO Full Analysis → SPL Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).